Government grant to provide more accurate breast cancer diagnosis
Vinnova grants SEK 20 million to the Swedish AI Precision Pathology (SwAIPP) consortia to develop and implement AI-based precision diagnostics in cancer care. The consortia consist of Stratipath, Karolinska Institutet, the pathology clinics in the Kalmar, VÀstmanland and SkÄne regions, Microsoft, Roche Diagnostics, Philips, Bröstcancerförbundet, Prevas and Helseplan.
Annals of Oncology
A published high-impact scientific article from Karolinska Institutet shows that AI-supported image analysis can stratify intermediate-grade breast cancers into low or high grade. This has strong prognostic value and potential to revolutionize breast pathology.
Study shows large variation in biomarkers and grade among Swedish pathology labs calls for AI-supported image analysis
Abstract: We compared estrogen receptor (ER), progesterone receptor (PR), human epidermal growth-factor receptor 2 (HER2), Ki67, and grade scores among the pathology departments in Sweden. We investigated how ER and HER2 positivity rates affect the distribution of endocrine and HER2-targeted treatments among oncology departments. All breast cancer patients diagnosed between 2013 and 2018 in Sweden […]
Stratipath is featured in NyTeknik, Swedenâs largest technology news magazine.
Stratipath is featured in NyTeknik, Swedenâs largest technology news magazine.
Read more at NyTeknik or MSN
Stratipath is featured in Dagens Industri, Swedenâs largest business news magazine.
Read the article
Stratipath is featured in AffÀrsvÀrlden.
Read the article
Stratipath is accepted to the Karolinska Institutet Innovations incubator.
Read the article